Key Takeaways
- A consortium led by Advent International and FedEx (FDX) has agreed to acquire Polish parcel-delivery firm InPost (INPST) for €7.8 billion ($9.22 billion), representing a 50% premium per share.
- Novo Nordisk (NVO) shares surged 8.6% after Hims & Hers Health Inc. (HIMS) scrapped plans for a copycat version of its popular weight-loss drug, Wegovy, following regulatory and legal pressures.
- UniCredit (UCG) announced plans to return €50 billion to investors over five years, sending its shares up 3.9%.
- Japan's Ishin co-leader Hirofumi Yoshimura confirmed an ongoing pursuit of a joint agreement with the ruling Liberal Democratic Party (LDP), signaling continued political stability and policy cooperation.
- European markets showed positive momentum, with Britain's FTSE 100 rising 0.3%, France's CAC 40 up 0.25%, and Spain's IBEX gaining 0.66%.
European markets opened with positive sentiment today, driven by significant corporate developments and a major acquisition in the logistics sector. Meanwhile, political developments in Japan and economic data from Switzerland also captured investor attention.
InPost Acquired in Multi-Billion Euro Deal
Polish parcel-delivery giant InPost (INPST) is set to be acquired by a consortium comprising Advent International, FedEx (FDX), A&R, and PPF Group. The all-cash offer values InPost at €7.8 billion ($9.22 billion), with shares priced at €15.60 each. This represents a substantial 50% premium compared to InPost's share price on January 2, before news of the potential deal emerged. The acquisition, supported by shareholders holding 48% of outstanding shares, is expected to close in the second half of 2026. Following the news, InPost shares saw a significant increase of 13.5% in early European trading.
Upon completion, Advent and FedEx (FDX) will each hold a 37% stake in InPost, while A&R will hold 16% and PPF 10%. The consortium aims to leverage InPost's extensive network of 61,000 automated parcel lockers to expand its reach across Europe.
Pharma Sector Sees Volatility as Hims Scraps Wegovy Copycat
Novo Nordisk (NVO) experienced a notable surge of 8.6% in its stock price after Hims & Hers Health Inc. (HIMS) announced it would halt the sale of its copycat version of Novo Nordisk's popular weight-loss drug, Wegovy. This decision by Hims & Hers comes after the company initially launched a cheaper compounded oral semaglutide, priced at $49 for the first month, triggering immediate backlash and legal threats from Novo Nordisk.
Novo Nordisk had accused Hims & Hers of "illegal compounding" and posing "significant risk to patients," while the FDA also indicated it would limit access to active ingredients for such copycat GLP-1 drugs. The move highlights the ongoing tension and legal battles within the rapidly expanding weight-loss drug market, where intellectual property and regulatory compliance are key concerns.
UniCredit Plans Massive Capital Return
Italian banking giant UniCredit (UCG) saw its shares climb 3.9% after revealing ambitious plans to return €50 billion to investors over the next five years. This significant capital return initiative underscores the bank's strong financial position and commitment to shareholder value.
The announcement follows UniCredit's previous strategic moves, including the acquisition of an approximately 9% stake in Commerzbank AG in September 2024. UniCredit also received approval from the European Central Bank to potentially increase its shareholding in Commerzbank to 29.9% by March 2025, though the timeline for a final decision on this investment may extend into 2026.
Japan's LDP and Ishin Continue Coalition Talks
In Japanese politics, Ishin co-leader Hirofumi Yoshimura confirmed that the party is continuing to pursue a joint agreement with the ruling Liberal Democratic Party (LDP). This ongoing collaboration is part of efforts to form a stable coalition government, with discussions having previously led to a coalition deal signed in October 2025. The agreement outlines policy cooperation across various areas, including constitutional revision and defense buildup. A joint conference is expected to be established to coordinate policies between the two parties. The continued pursuit of this agreement suggests a focus on political stability and a unified policy agenda.
European Indices Show Gains, Swiss Confidence Remains Subdued
Major European stock indices posted gains, with Britain's FTSE 100 rising 0.3%. France's CAC 40 increased by 0.25%, and Spain's IBEX climbed 0.66%, reflecting a broadly positive market sentiment across the continent.
In Switzerland, the SECO Consumer Confidence index for January registered -30.1, slightly below the estimated -29.5 but an improvement from the previous -30.7. The first-quarter Consumer Confidence also showed a modest rise to -32 from -34. While showing a slight uptick, consumer confidence in Switzerland remains in negative territory, indicating ongoing caution among households.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.